文献速递类风湿关节炎其他结缔组织病

新西兰坎特伯雷地区类风湿关节炎相关间质性肺病:一项回顾性队列研究

Rheumatoid interstitial lung disease in Canterbury, Aotearoa New Zealand - A retrospective cohort study.
PubMed 文献 · Semin Arthritis Rheum · 2023-12-23

该回顾性队列研究在坎特伯雷地区卫生委员会辖区识别2006–2008年和2011–2013年两个时段内≥18岁类风湿关节炎患者并随访至2019年6月30日。结果显示RA-ILD患病率每10万人分别为10.97和14.74,10年累积发病率4.47%,类风湿因子阳性、其他关节外表现和皮下结节与发病风险升高相关,标化死亡比为3.90。

要点

  • RA-ILD每10万人患病率第一时段10.97、第二时段14.74,10年累积发病率4.47%。
  • 类风湿因子阳性、其他关节外表现和皮下结节与RA-ILD发病风险升高相关。
  • RA-ILD标化死亡比3.90,CT上ILD范围>20%与死亡率相关。

核心结论

  • 临床上明显的RA-ILD约发生于5%的类风湿关节炎患者,死亡率较一般人群增加近四倍,影像学范围是最重要的预后因素。

研究设计与样本

  • 回顾性队列研究,纳入坎特伯雷地区卫生委员会辖区2006年1月1日至2008年12月31日(第一时段)和2011年1月1日至2013年12月31日(第二时段)期间≥18岁的类风湿关节炎患者,随访至2019年6月30日。

主要发现

  • RA-ILD每10万人患病率第一时段为10.97(95%CI 7.53,14.42),第二时段为14.74(95%CI 10.84,18.63)。
  • 在评估发病风险因素的个体中,10年ILD累积发病率为4.47%(95%CI 3.14,6.14)。
  • 调整年龄后,类风湿因子阳性(HR 3.73,95%CI 1.32,10.56)、除RA-ILD外的其他关节外表现(HR 4.48,95%CI 2.36,8.48)和皮下类风湿结节(HR 4.66,95%CI 2.34,9.26)与RA-ILD发病风险升高相关。
  • RA-ILD标化死亡比为3.90(95%CI 2.55,5.72),与一般人群相比。
  • 胸部CT上ILD范围>20% vs <20%与死亡率相关(HR 4.47,95%CI 1.67,11.96)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rheumatoid arthritis associated interstitial lung disease (RA-ILD), is an important extra-articular manifestation of rheumatoid arthritis (RA). The frequency, risk factors, and prognosis of RA-ILD are incompletely understood. AIMS: To determine the prevalence and incidence, clinical characteristics and risk factors for development, and outcomes of persons with RA-ILD in the population of the Canterbury District Health Board (CDHB) catchment area. METHODS: Individuals aged ≥ 18 years with RA, resident in the CDHB catchment area between 1 January 2006 and 31 December 2008 (Period One), and 1 January 2011 to 31 December 2013 (Period Two) were identified by medical record review and followed until 30 June 2019. Individuals with RA-ILD as defined by pre-specified criteria were identified. The association between demographic and clinical characteristics and RA-ILD development and mortality was examined using Cox-proportional hazards models. RESULTS: The prevalence of RA-ILD per 100,000 was 10.97 (95 % CI 7.53,14.42) for Period One, and 14.74 (95 % CI 10.84,18.63) for Period Two. Among individuals evaluated for risk factors for RA-ILD development, the estimated cumulative incidence of ILD at 10 years was 4.47 % (95 % CI 3.14, 6.14). After adjusting for age, rheumatoid factor positivity (HR 3.73, 95 % CI, 1.32,10.56), extra-articular manifestations other than RA-ILD (HR 4.48, 95 % CI 2.36,8.48), and subcutaneous rheumatoid nodules (HR 4.66, 95 % CI 2.34, 9.26) were associated with increased risk of developing RA-ILD. The standardised mortality ratio for RA-ILD was 3.90 (95 % CI 2.55,5.72) compared to the general population. Extent of ILD on CT chest was associated with mortality (HR for >20% vs. < 20 % 4.47, 95 % CI 1.67,11.96). CONCLUSIONS: Clinically evident RA-ILD occurred in approximately 5 % of individuals with RA. Mortality was increased almost fourfold compared to the general population. Radiologic extent was the most important prognostic factor.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Farquhar HJ, Beckert L, Edwards AL, et al. Rheumatoid interstitial lung disease in Canterbury, Aotearoa New Zealand - A retrospective cohort study. Semin Arthritis Rheum. 2023. PMID: 38157761. doi:10.1016/j.semarthrit.2023.152359

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。